Exeter Financial LLC Acquires 199 Shares of The Clorox Company (NYSE:CLX)

Exeter Financial LLC increased its holdings in The Clorox Company (NYSE:CLXFree Report) by 2.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,986 shares of the company’s stock after buying an additional 199 shares during the period. Exeter Financial LLC’s holdings in Clorox were worth $1,297,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Insight Folios Inc grew its stake in shares of Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after acquiring an additional 63 shares during the period. SPC Financial Inc. lifted its holdings in Clorox by 2.2% during the second quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock valued at $476,000 after purchasing an additional 75 shares in the last quarter. Massmutual Trust Co. FSB ADV boosted its position in shares of Clorox by 17.2% in the third quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $83,000 after purchasing an additional 75 shares during the period. Empower Advisory Group LLC increased its stake in shares of Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after purchasing an additional 78 shares in the last quarter. Finally, Aviance Capital Partners LLC raised its position in shares of Clorox by 2.7% during the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after purchasing an additional 80 shares during the period. 78.53% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on CLX shares. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and increased their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. DA Davidson upped their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Evercore ISI reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Finally, JPMorgan Chase & Co. upped their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $157.46.

Get Our Latest Stock Analysis on CLX

Clorox Trading Down 0.2 %

NYSE CLX opened at $157.32 on Tuesday. The stock has a market cap of $19.47 billion, a PE ratio of 54.82, a PEG ratio of 3.04 and a beta of 0.42. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company’s 50-day moving average price is $164.55 and its 200-day moving average price is $156.00. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm earned $0.49 EPS. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. Equities research analysts forecast that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.10%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is 170.03%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.